Intervention

Placebo ELLIPTA inhaler

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

2 shown

A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02731846 · 2016-06-01

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With AsthmaNCT02586506 · 2015-10-01

Common conditions

Asthma1 Pulmonary Disease, Chronic Obstructive1

Leading sponsors

GlaxoSmithKline2

Trial status mix

COMPLETED1

WITHDRAWN1

Phase mix

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.